Exagen SG&A Expenses 2019-2024 | XGN
Exagen sg&a expenses from 2019 to 2024. Sg&a expenses can be defined as the sum of all selling, general and administrative expenses.
| Exagen Annual SG&A Expenses (Millions of US $) |
|
|---|---|
| 2024 | $41 |
| 2023 | $47 |
| 2022 | $52 |
| 2021 | $45 |
| 2020 | $37 |
| 2019 | $29 |
| 2018 | $20 |
| Exagen Quarterly SG&A Expenses (Millions of US $) |
|
|---|---|
| 2024-12-31 | $10 |
| 2024-09-30 | $10 |
| 2024-06-30 | $10 |
| 2024-03-31 | $11 |
| 2023-12-31 | $12 |
| 2023-09-30 | $11 |
| 2023-06-30 | $12 |
| 2023-03-31 | $12 |
| 2022-12-31 | $13 |
| 2022-09-30 | $14 |
| 2022-06-30 | $13 |
| 2022-03-31 | $12 |
| 2021-12-31 | $12 |
| 2021-09-30 | $12 |
| 2021-06-30 | $11 |
| 2021-03-31 | $10 |
| 2020-12-31 | $10 |
| 2020-09-30 | $9 |
| 2020-06-30 | $8 |
| 2020-03-31 | $10 |
| 2019-12-31 | $8 |
| 2019-09-30 | $7 |
| 2019-06-30 | $7 |
| 2019-03-31 | $6 |
| 2018-12-31 | |
| 2018-09-30 | $5 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | MED PRODUCTS | $0.111B | $0.056B |
| Exagen Inc. is engaged in transforming the care continuum for patients suffering from debilitating and chronic autoimmune diseases. It developed and commercialises testing products under AVISE brand. Exagen Inc. is based in Vista, California. | |||